ClinicalTrials.Veeva

Menu

Neutrophil, Lymphocyte and Platelet as a Predictor for AKI and Mortality

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Acute Kidney Injury

Treatments

Procedure: Cardiovascular surgery with cardiopulmonary bypass

Study type

Observational

Funder types

Other

Identifiers

NCT02916043
1604-038-753

Details and patient eligibility

About

Cell-count related risk factors for acute kidney injury after cardiovascular surgery have been reported. The authors attempted to investigate whether the perioperative cell counts of neutrophil, lymphocyte, platelet are associated with the postoperative acute kidney injury and long-term mortality after cardiovascular surgery using cardiopulmonary bypass.

Full description

Acute kidney injury (AKI) after cardiovascular surgery remains a serious complication associated with increased mortality for up to 10 years. The incidence of AKI after cardiovascular surgery is as high as 55% and the incidence of renal replacement therapy (RRT) to be up to 8 %.

Cell-count related risk factors for acute kidney injury after cardiovascular surgery have been reported. The authors attempted to investigate whether the perioperative cell counts of neutrophil, lymphocyte, platelet are associated with the postoperative acute kidney injury and long-term mortality after cardiovascular surgery using cardiopulmonary bypass.

Enrollment

1,099 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients who underwent cardiovascular surgeries with cardiopulmonary bypass (CPB), including valve replacement and surgery on the thoracic aorta at the Seoul National University Hospital between 2007 and 2015

Exclusion criteria

  • Missing preoperative serum creatinine (sCr) values
  • Missing preoperative platelet, neutrophil and lymphocyte counts
  • Patients who underwent preoperative hemodialysis

Trial design

1,099 participants in 1 patient group

Cardiovascular surgery with cardiopulmonary bypass
Description:
Cardiovascular surgery with cardiopulmonary bypass
Treatment:
Procedure: Cardiovascular surgery with cardiopulmonary bypass

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems